WO2020056713A1 - Method for preparing high-purity nad - Google Patents

Method for preparing high-purity nad Download PDF

Info

Publication number
WO2020056713A1
WO2020056713A1 PCT/CN2018/106903 CN2018106903W WO2020056713A1 WO 2020056713 A1 WO2020056713 A1 WO 2020056713A1 CN 2018106903 W CN2018106903 W CN 2018106903W WO 2020056713 A1 WO2020056713 A1 WO 2020056713A1
Authority
WO
WIPO (PCT)
Prior art keywords
nad
solution
purity
preparing high
ethanol
Prior art date
Application number
PCT/CN2018/106903
Other languages
French (fr)
Chinese (zh)
Inventor
张冬民
张琦
戴柱
Original Assignee
邦泰生物工程(深圳)有限公司
邦泰合盛生物科技(深圳)有限公司
江西安泽麦生物科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 邦泰生物工程(深圳)有限公司, 邦泰合盛生物科技(深圳)有限公司, 江西安泽麦生物科技有限公司 filed Critical 邦泰生物工程(深圳)有限公司
Priority to PCT/CN2018/106903 priority Critical patent/WO2020056713A1/en
Priority to CN201880037981.3A priority patent/CN111065644B/en
Publication of WO2020056713A1 publication Critical patent/WO2020056713A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide

Abstract

A method for preparing high-purity NAD, comprising: adjusting a pH value to 6.0-8.0, removing insoluble substances, heating to 35 ± 1°C, adding ethanol, cooling to 6 ± 0.5°C, crystallizing, filtering, heating a filtrate to 25-30°C, adjusting the pH value to 1.5-3.0, adding an NAD seed crystal, cooling to 12 ± 0.5°C, crystallizing, adding ethanol again after crystallinity reaching 40%, cooling to 3 ± 0.5°C, crystallizing, filtering after the crystallinity being above 90%, and drying a filter cake to obtain a high-purity NAD product.

Description

一种制备高纯度NAD的方法Method for preparing high-purity NAD 技术领域Technical field
本发明涉及核苷酸类辅酶的纯化的技术领域,特别涉及对NAD的粗品溶液进行纯化的方法。The invention relates to the technical field of purification of nucleotide coenzymes, and in particular to a method for purifying a crude solution of NAD.
背景技术Background technique
NAD是氧化型烟酰胺腺嘌呤二核苷酸(Nicotinamide Adenine Dinucleotide)的英文缩写形式,是存在于包括人类细胞在内的所有活细胞中的一种生理物质,对身体无副作用,这种物质是很多可催化氧化—还原反应的酶的辅助因子,因此被称为辅酶Ⅰ。NAD is the abbreviated form of Nicotinamide Adenine Dinucleotide. It is a physiological substance that exists in all living cells, including human cells, and has no side effects on the body. This substance is Cofactors of many enzymes that catalyze oxidation-reduction reactions are therefore called coenzymes I.
NAD在生物体内参与细胞物质代谢、能量合成、细胞DNA修复等多种生理活动,是线粒体中能量产生链中的控制标志物,对机体免疫能力有重要作用。如今,NAD被广泛应用于化工催化反应、原料药生产、保健品生产、以及化妆品等行业,而随着对NAD在疾病的治疗和预防方面的深入研究,NAD作为医药保健品的重要性日益凸显出来,市场需求量逐年增加。NAD participates in a variety of physiological activities such as cell material metabolism, energy synthesis, and cell DNA repair in the body. It is a control marker in the energy production chain in mitochondria and plays an important role in the body's immune capacity. Today, NAD is widely used in chemical catalytic reactions, API production, health care product manufacturing, and cosmetics industries. With the in-depth study of NAD in the treatment and prevention of diseases, the importance of NAD as a health care product has become increasingly prominent. Since then, the market demand has increased year by year.
目前,NAD的制备方法主要分为化学合成法和生物催化法,其中的生物催化法又包括生物发酵法和酶催化法,因其相较于化学合成法具有绿色环保无公害的优点而逐渐成为主流方向。通过生物催化法制备NAD得到的粗产物溶液(酶反应液或者生物发酵液)中除NAD外还含有大量杂质,NAD的纯度只有20-40%,故还需经过进一步的分离纯化处理才能得到较为纯净的NAD产品。At present, the preparation methods of NAD are mainly divided into chemical synthesis methods and biocatalytic methods. Among them, biocatalytic methods include biological fermentation methods and enzyme catalytic methods. Compared with chemical synthesis methods, it has gradually become environmentally friendly and harmless. Mainstream direction. The crude product solution (enzyme reaction solution or biological fermentation broth) prepared by biocatalytic method contains a large amount of impurities in addition to NAD. The purity of NAD is only 20-40%, so it needs to be further separated and purified to obtain a comparative Pure NAD products.
中国发明专利CN105131065B一种氧化型辅酶I的制备方法以及中国发明专利CN105481923B一种烟酰胺腺嘌呤二核苷酸的制备方法中均公开了一种NAD的分离纯化方法,其中都是主要采用树脂柱进行分离和纯化。这种利用树脂柱进行分离纯化的方法操作繁琐、耗时长且溶剂使用量大,不利于大工业化生产,其后期还需对树脂进行活化处理,会用到大量的酸、碱、盐等溶剂,环境污染较大且成本较高。Chinese invention patent CN105131065B, a method for preparing an oxidized coenzyme I, and Chinese invention patent CN105481923B, a method for preparing nicotinamide adenine dinucleotide, both disclose a method for separating and purifying NAD, which mainly uses resin columns. Isolate and purify. This separation and purification method using a resin column is cumbersome, time-consuming, and uses a large amount of solvents, which is not conducive to large-scale industrial production. In the later stage, the resin needs to be activated and a large amount of solvents such as acids, alkalis, and salts will be used. Environmental pollution is relatively large and costly.
技术问题technical problem
本发明的目的在于解决现有的对NAD进行分离纯化的方法所存在的操作繁琐、耗时长、成本高、污染大的技术问题,提供一种操作简单快捷、成本低廉、污染小的制备高纯度NAD的方法,用于对NAD的粗品溶液进行纯化处理。The purpose of the present invention is to solve the technical problems of tedious operation, time-consuming, high cost, and large pollution in the existing method for separating and purifying NAD, and to provide a high-purity preparation with simple and fast operation, low cost, and low pollution. NAD method is used to purify the crude NAD solution.
技术解决方案Technical solutions
为实现上述目的,本发明提供了一种制备高纯度NAD的方法,包括:1)将NAD的粗品溶液的pH值调节至6.0~8.0,然后除去不溶物;2)升温至35±1℃,并加入乙醇至溶液中乙醇的终浓度为20%~40%体积分数,搅拌至澄清;3)降温至6±0.5℃,保持pH值为6.0~8.0进行结晶,待晶体析出后进行过滤,收集滤液;4)将步骤3)的滤液升温至25~30℃,然后调节pH值至1.5~3.0,并搅拌至澄清;5)加入NAD晶种,然后降温至12±0.5℃,保持pH值为1.5~3.0,待溶液中NAD的结晶率达到40%时,再加入乙醇至溶液中乙醇的终浓度为10%~30%体积分数,混合均匀;6)降温至3±0.5℃,保持pH值为1.5~3.0进行结晶,待溶液中NAD的结晶率在90%以上时,过滤,收集滤饼,经干燥后即得高纯度NAD产品。To achieve the above object, the present invention provides a method for preparing high-purity NAD, including: 1) adjusting the pH value of the crude NAD solution to 6.0 to 8.0, and then removing insoluble matters; 2) increasing the temperature to 35 ± 1 ° C, And add ethanol to the final concentration of ethanol in the solution is 20% to 40% by volume, stir until clear; 3) cool to 6 ± 0.5 ℃, maintain the pH value of 6.0 to 8.0 to crystallize, after the crystals precipitate, filter and collect The filtrate; 4) The temperature of the filtrate in step 3) was raised to 25-30 ° C, and then the pH was adjusted to 1.5-3.0, and stirred until clear; 5) The NAD seed was added, and then the temperature was lowered to 12 ± 0.5 ° C, and the pH was maintained. 1.5 ~ 3.0, when the crystallization rate of NAD in the solution reaches 40%, add ethanol until the final concentration of ethanol in the solution is 10% -30% by volume, and mix well; 6) Reduce the temperature to 3 ± 0.5 ℃ and maintain the pH Crystallize from 1.5 to 3.0. When the crystallization rate of NAD in the solution is more than 90%, filter, collect the filter cake, and obtain a high-purity NAD product after drying.
本发明方法中,步骤1)的NAD的粗品溶液是指除了含有NAD之外还含有大量杂质的溶液,如:将从市场中购买的纯度不够高的NAD产品溶解于水后得到的溶液,或者生物催化法制备NAD得到的粗产物溶液。In the method of the present invention, the crude solution of NAD in step 1) refers to a solution containing a large amount of impurities in addition to NAD, such as a solution obtained by dissolving NAD products purchased from the market with insufficient purity in water, or The crude product solution obtained by NAD was prepared by biocatalysis.
优选地,控制NAD的粗品溶液的浓度为100~300mmol/L,以确保后期能够析出足够多的晶体,从而保证足够高的收率。Preferably, the concentration of the crude NAD solution is controlled to 100-300 mmol / L to ensure that enough crystals can be precipitated in the later stage, thereby ensuring a sufficiently high yield.
生物催化(biocatalysis)是指利用生物酶或者生物有机体(细胞、细胞器、组织等)作为催化剂进行物质转化的过程(分别称为酶催化和生物发酵),这种反应过程又称为生物转化(biotransformation)。生物催化中常用的生物有机体主要是微生物,其本质是利用微生物细胞内的酶进行催化,促进生物转化的进程。生物催化法具有作用条件温和(基本上在常温、中性、水等环境中完成);独特、高效的底物选择性(因为催化过程中的酶具有专一性的特点,即一种酶只能催化一种特定的底物发生反应,但是一种底物则可能被多种酶催化);对于手性活性药物成分的合成具有独特性的优点。Biocatalysis refers to the process of transforming substances using biological enzymes or biological organisms (cells, organelles, tissues, etc.) as catalysts (referred to as enzyme catalysis and biological fermentation respectively). This reaction process is also called biotransformation ). The biological organisms commonly used in biocatalysis are mainly microorganisms. The essence is to use enzymes in the cells of microorganisms to catalyze and promote the process of biological transformation. The biocatalytic method has mild action conditions (basically completed in normal temperature, neutral, water and other environments); unique and efficient substrate selectivity (because the enzyme in the catalytic process has specific characteristics, that is, an enzyme only Can catalyze a specific substrate to react, but one substrate may be catalyzed by multiple enzymes); it has unique advantages for the synthesis of chiral active pharmaceutical ingredients.
本发明所谓生物催化法制备NAD得到的粗产物溶液具体是指利用生物酶催化底物转化成NAD后的酶反应液,或者是利用含有生物酶的生物有机体经发酵培养和诱导表达后去除生物有机体后的含有NAD的生物发酵液。其中所谓生物酶是指可以特异性催化底物转化成NAD的酶,所谓底物是指可以转化成NAD的前体物质。譬如,底物可以是NMN和ATP,也可以是能够转化成NMN或者ATP的前体物质,与之对应的生物酶则是烟酰胺单核苷酸腺苷转移酶,或者是烟酰胺单核苷酸腺苷转移酶和一种或者多种其他酶的联合使用。The so-called crude product solution obtained by NAD prepared by the biocatalytic method in the present invention specifically refers to an enzyme reaction solution obtained by using a biological enzyme to catalyze the conversion of a substrate into NAD, or to remove a biological organism by fermentation and induction of expression using a biological organism containing a biological enzyme After the fermentation broth containing NAD. The so-called biological enzyme refers to an enzyme that can specifically catalyze the conversion of a substrate into NAD, and the so-called substrate refers to a precursor substance that can be converted into NAD. For example, the substrate can be NMN and ATP, or a precursor substance that can be converted into NMN or ATP. The corresponding biological enzyme is nicotinamide mononucleotide adenosyltransferase, or nicotinamide mononucleoside. Acid adenosine transferase is used in combination with one or more other enzymes.
本发明方法步骤1)中将pH值调节为6.0~8.0的作用在于:一方面使溶液中含有的杂质(主要为高价阳离子)以沉淀的形式析出;另一方面,为后续的结晶提供必要的pH条件。优选地,使用氢氧化钠调节pH值。The effect of adjusting the pH value to 6.0 to 8.0 in step 1) of the method of the present invention is that on the one hand, impurities (mainly high-valent cations) contained in the solution are precipitated in the form of precipitation; on the other hand, it provides necessary for subsequent crystallization pH conditions. Preferably, the pH is adjusted using sodium hydroxide.
优选地,本发明方法步骤1)中,除去不溶物的方式为进行微滤处理。微滤又称微孔过滤,以微孔滤膜为过滤介质,在0.1~0.3MPa的压力推动下,截留0.1~1微米之间的颗粒和细菌,但能允许大分子有机物和无机盐等通过。本发明方法中使用的微滤膜优选为0.1~0.5μm孔径的中空纤维膜。Preferably, in the step 1) of the method of the present invention, the insoluble matter is removed by performing a microfiltration treatment. Microfiltration, also known as microfiltration, uses a microporous membrane as a filter medium. Under the pressure of 0.1 to 0.3 MPa, it traps particles and bacteria between 0.1 and 1 micron, but allows macromolecular organic substances and inorganic salts to pass through. . The microfiltration membrane used in the method of the present invention is preferably a hollow fiber membrane having a pore diameter of 0.1 to 0.5 μm.
本发明方法步骤2)中升温至35±1℃的目的在于防止加入乙醇后溶液中形成胶状沉淀,从而吸附部分NAD,并且增加过滤的难度。The purpose of step 2) of the method of the present invention is to raise the temperature to 35 ± 1 ° C. The purpose is to prevent the formation of a gelatinous precipitate in the solution after adding ethanol, thereby adsorbing some NAD, and increasing the difficulty of filtration.
本发明方法步骤2)中加入乙醇溶液的作用在于:乙醇作为底物和副产物结晶的不良溶液,有利于加快和提高底物和副产物的结晶的转化率。The effect of adding the ethanol solution in step 2) of the method of the present invention is that ethanol is a poor solution for crystallization of the substrate and by-products, which is beneficial to speeding up and increasing the conversion rate of the crystallization of the substrates and by-products.
本发明方法步骤3)中,保持pH值为6.0~8.0的原因在于:NAD在6.0以上不能析出晶体,而杂质(主要为催化的底物、副产物和杂蛋白)结晶的适宜pH值则在6.0~8.0;降温至6±0.5℃有利于杂质最大限度地结晶析出。In step 3) of the method of the present invention, the reason why the pH value is maintained at 6.0 to 8.0 is that crystals cannot be precipitated when the NAD is above 6.0, and the suitable pH value of the crystals of impurities (mainly catalyzed substrates, by-products and heteroproteins) is 6.0 ~ 8.0; cooling down to 6 ± 0.5 ℃ is conducive to the maximum crystallization of impurities.
当溶液中NAD的纯度大于80%时,对NAD进行结晶时的效率最好,得到的产品纯度最高。因此,本发明方法步骤3)中,优选地,待晶体析出至溶液中NAD的纯度在80%以上时,进行过滤。When the purity of NAD in the solution is greater than 80%, the efficiency of crystallization of NAD is the best, and the purity of the obtained product is the highest. Therefore, in step 3) of the method of the present invention, preferably, the crystals are precipitated until the purity of the NAD in the solution is above 80%, and then filtering is performed.
本发明方法中的过滤是指采用物理方法将溶液中的固体和液体进行分离的过程,常见的过滤方法均适用于本发明,包括常压过滤、减压过滤、离心过滤等。优选地,本发明方法步骤3)中用500目的过滤装置进行过滤。The filtration in the method of the present invention refers to a process of separating solids and liquids in a solution by a physical method. Common filtration methods are applicable to the present invention, including atmospheric pressure filtration, reduced pressure filtration, centrifugal filtration, and the like. Preferably, in step 3) of the method of the present invention, filtration is performed using a 500-mesh filtration device.
本发明方法步骤4)中,将pH值调节至1.5~3.0,有利于NAD结晶析出,优选地,选用盐酸调节pH值;升温至25~30℃可避免NAD在调节pH的过程中形成油状沉淀的过渡态,导致难以析出结晶。In step 4) of the method of the present invention, adjusting the pH value to 1.5 to 3.0 is beneficial to the precipitation of NAD. Preferably, hydrochloric acid is used to adjust the pH value; raising the temperature to 25 to 30 ° C can prevent NAD from forming an oily precipitate during the pH adjustment process. Transition state, making it difficult to precipitate crystals.
优选地,本发明方法步骤5)中,NAD晶种的加入量为步骤3)的滤液中含有的NAD质量的0.5%~1.5%。Preferably, in step 5) of the method of the present invention, the amount of NAD seed added is 0.5% to 1.5% of the mass of NAD contained in the filtrate of step 3).
因直接将温度从25~30℃降至3±0.5℃或者一次性加入过量的乙醇溶液会造成NAD形成油状过渡态,从而延迟结晶时间、降低晶体的转化率甚至导致结晶失败。本发明方法步骤5)和步骤6)中,将NAD的结晶过程分为两个阶段操作,分别为:第一阶段降温至12±0.5℃,并在NAD的结晶率达到40%以上时加入乙醇至溶液中乙醇的终浓度为10%~30%体积分数;第二阶段降再温至3±0.5℃。这样做可有效避NAD形成油状过渡态的情况发生,从而提高了结晶效率和晶体转化率。Because directly lowering the temperature from 25-30 ° C to 3 ± 0.5 ° C or adding an excessive amount of ethanol solution at one time will cause NAD to form an oily transition state, thereby delaying the crystallization time, reducing the crystal conversion rate and even causing crystallization failure. In steps 5) and 6) of the method of the present invention, the crystallization process of NAD is divided into two stages, which are: the first stage is cooled to 12 ± 0.5 ° C, and ethanol is added when the crystallization rate of NAD reaches more than 40% The final concentration of ethanol in the solution is 10% -30% by volume; in the second stage, the temperature is reduced to 3 ± 0.5 ° C. This can effectively avoid the occurrence of the oily transition state of NAD, thereby improving the crystallization efficiency and crystal conversion rate.
优选地,在对步骤6)的滤饼进行干燥之前,先用10~15℃的体积分数为30%±2%的乙醇水溶液对滤饼进行洗涤。Preferably, before the filter cake of step 6) is dried, the filter cake is washed with a 30% ± 2% ethanol aqueous solution with a volume fraction of 10 to 15 ° C.
优选地,采用真空干燥法对步骤6)的滤饼进行干燥。Preferably, the filter cake of step 6) is dried by a vacuum drying method.
当NAD的粗品溶液为生物催化法制备NAD得到的粗产物溶液时,为了提高分离纯化的效率,同时提高NAD结晶的收率,优选地,本发明的方法还包括:在步骤1)之前,将粗产物溶液进行浓缩处理,以除去大量的水分。本发明中的浓缩是指采用物理方法使溶剂减少而提高溶液的浓度的过程,包括减压蒸馏法、超过滤法、透析法、吸附法、冷冻干燥法等。When the crude NAD solution is a crude product solution prepared by biocatalytic NAD, in order to improve the efficiency of separation and purification and increase the yield of NAD crystals, preferably, the method of the present invention further includes: before step 1), The crude product solution was concentrated to remove a large amount of water. Concentration in the present invention refers to a process in which the concentration of a solution is increased by reducing the solvent using a physical method, and includes a vacuum distillation method, an ultrafiltration method, a dialysis method, an adsorption method, and a freeze-drying method.
优选地,上述浓缩处理采用纳滤浓缩。纳滤是一种介于反渗透和超滤之间的压力驱动膜分离过程,以纳滤膜为过滤介质,纳滤膜的孔径范围在几个纳米左右,允许溶剂分子或某些相对分子质量较小的溶质或低价离子透过,从而达到分离和浓缩的效果。优选地,本发明选用的纳滤膜的截留分子量为200~400道尔顿。Preferably, the above-mentioned concentration treatment is concentrated by nanofiltration. Nanofiltration is a pressure-driven membrane separation process between reverse osmosis and ultrafiltration. Nanofiltration membranes are used as filter media. The pore size of nanofiltration membranes is about several nanometers, allowing solvent molecules or certain relative molecular masses. Smaller solutes or low-priced ions penetrate to achieve separation and concentration effects. Preferably, the molecular weight cut-off of the nanofiltration membrane used in the present invention is 200-400 Daltons.
浓缩处理后的粗产物溶液的浓度过低会降低后续NAD结晶的收率,而浓度过高则会增大纳滤膜的压力,减短纳滤膜的寿命。优选地,将粗产物溶液浓缩至溶液中NAD的浓度为100~300mmol/L。If the concentration of the crude product solution after the concentration treatment is too low, the yield of subsequent NAD crystallization will be reduced, while if the concentration is too high, the pressure of the nanofiltration membrane will be increased, and the life of the nanofiltration membrane will be shortened. Preferably, the crude product solution is concentrated to a concentration of NAD in the solution of 100-300 mmol / L.
对于酶催化反应而言,在反应过程中还需使用铁、镍、镁等用于激活酶的激活剂,这些激活剂在纳滤浓缩的过程中会形成大量无机盐离子沉淀,从而堵塞纳滤膜,所以,优选地,在纳滤浓缩之前,需要对粗产物溶液进行如下预处理:将粗产物溶液的pH值调节至3.0~5.0,然后进行微滤处理,收集微滤液。For enzyme-catalyzed reactions, iron, nickel, magnesium, and other activators for activating enzymes need to be used during the reaction. These activators will form a large amount of inorganic salt ion precipitation during the nanofiltration concentration process, thereby blocking the nanofiltration. Membrane, so, preferably, prior to nanofiltration concentration, the crude product solution needs to be pretreated as follows: the crude product solution is adjusted to a pH value of 3.0 to 5.0, and then subjected to a microfiltration treatment to collect the microfiltrate.
优选地,微滤过程中使用的微滤膜为0.1~0.5μm孔径的中空纤维膜。Preferably, the microfiltration membrane used in the microfiltration process is a hollow fiber membrane having a pore diameter of 0.1 to 0.5 μm.
有益效果Beneficial effect
与现有技术相比,本发明提供的NAD的纯化方法具有收率高和纯化产物纯度高的优点.,经工业实践证实,采用该纯化方法可从生物催化法制备NAD的粗产物溶液中制备得到纯度在99%以上的NAD纯品,且收率在85%以上。该纯化方法操作简单快捷,无需使用大量有毒有害试剂,对环境污染小,且纯化成本低廉,适宜规模化大工业化从生物酶反应液和生物发酵液中分离纯化NAD产品。Compared with the prior art, the NAD purification method provided by the present invention has the advantages of high yield and high purity of the purified product. It has been confirmed by industrial practice that the purification method can be prepared from a crude product solution of NAD prepared by a biocatalytic method. A pure NAD product with a purity of more than 99% was obtained, and the yield was more than 85%. The purification method is simple and fast to operate, does not require the use of a large number of toxic and harmful reagents, has little environmental pollution, and has low purification costs, and is suitable for large-scale industrialization to separate and purify NAD products from biological enzyme reaction solutions and biological fermentation solutions.
本发明的最佳实施方式Best Mode of the Invention
本发明提供的制备高纯度NAD的方法优选包括如下步骤:The method for preparing high-purity NAD provided by the present invention preferably includes the following steps:
1)        将生物催化法制备NAD得到的粗产物溶液的pH值调节至3.0~5.0,然后用0.1~0.5μm孔径的中空纤维膜进行微滤,收集微滤液;1) Adjusting the pH value of the crude product solution prepared by biocatalytic NAD to 3.0 to 5.0, and then performing microfiltration with a hollow fiber membrane having a pore size of 0.1 to 0.5 μm, and collecting the micro filtrate;
2)        将步骤1)的微滤液用截留分子量为200~400道尔顿的纳滤膜进行纳滤浓缩至NAD的浓度为100~300mmol/L;2) Nanofiltration of the microfiltrate from step 1) with a nanofiltration membrane having a molecular weight cutoff of 200 to 400 Daltons to a concentration of NAD of 100 to 300 mmol / L;
3)        用氢氧化钠溶液将步骤2)浓缩后的溶液的pH值调节至6.0~8.0,然后用0.1~0.5μm孔径的中空纤维膜进行微滤,收集微滤液;3) The pH value of the concentrated solution in step 2) was adjusted to 6.0 to 8.0 with a sodium hydroxide solution, and then microfiltration was performed with a hollow fiber membrane having a pore size of 0.1 to 0.5 μm, and the micro filtrate was collected;
4)        将步骤3)的微滤液升温至35±1℃,并加入乙醇至溶液中乙醇的终浓度为20%~40%体积分数,搅拌至澄清; 4) The micro filtrate of step 3) is heated to 35 ± 1 ° C, and ethanol is added to a final concentration of ethanol in the solution of 20% to 40% by volume, and stirred until clear;
5)        将步骤4)的澄清溶液降温至6±0.5℃,保持pH值为6.0~8.0进行结晶,待晶体析出至溶液中NAD的纯度在80%以上时,用500目的过滤装置进行过滤,收集滤液;5) The clarified solution of step 4) is cooled to 6 ± 0.5 ° C, and the pH is maintained at 6.0 to 8.0 for crystallization. When the crystals are precipitated until the purity of NAD in the solution is more than 80%, filtration is performed with a 500-mesh filtering device to collect the filtrate;
6)        将步骤5)的滤液升温至25~30℃,然后用盐酸调节pH值至1.5~3.0,并搅拌至澄清; 6) Raise the filtrate of step 5) to 25-30 ° C, then adjust the pH to 1.5-3.0 with hydrochloric acid, and stir until clear;
7)        向步骤6)的澄清溶液中加入占溶液中含有的NAD的质量的0.5%~1.5%的NAD晶种,然后降温至12±0.5℃,保持pH值为1.5~3.0,待溶液中NAD的结晶率达到40%时,再加入乙醇至溶液中乙醇的终浓度为10%~30%体积分数,混合均匀;7) Add 0.5% to 1.5% of the NAD seed contained in the solution to the clarified solution in step 6), and then lower the temperature to 12 ± 0.5 ° C and maintain the pH value of 1.5 to 3.0 until the NAD crystals in the solution When the rate reaches 40%, add ethanol to the solution to a final ethanol concentration of 10% to 30% by volume, and mix well;
8)        将步骤7)混合均匀的溶液降温至3±0.5℃,保持pH值为1.5~3.0进行结晶,待溶液中NAD的结晶率在90%以上时,过滤,收集滤饼;8) Step 7) cool the uniformly mixed solution to 3 ± 0.5 ° C and maintain the pH value of 1.5-3.0 for crystallization. When the crystallization rate of NAD in the solution is above 90%, filter and collect the filter cake;
用10~15℃的体积分数为30%±2%的乙醇水溶液对步骤8)的滤饼进行洗涤,然后将洗涤后的滤饼进行真空干燥,即得高纯度NAD产品。Wash the filter cake in step 8) with a 30% ± 2% ethanol aqueous solution at a volume fraction of 10 to 15 ° C, and then vacuum-dry the washed filter cake to obtain a high-purity NAD product.
本发明的实施方式Embodiments of the invention
下面结合具体实施例对本发明做进一步的详细说明,以下实施例是对本发明的解释,本发明并不局限于以下实施例。The following further describes the present invention in detail with reference to specific embodiments. The following embodiments explain the present invention, and the present invention is not limited to the following embodiments.
实施例1Example 1
处理对象:邦泰生物工程(深圳)有限公司采用生物酶催化法(以NMN和ATP为底物,用烟酰胺单核苷酸腺苷转移酶进行催化)制备NAD得到的四批粗产物溶液,测得这四批NAD粗产物溶液中NAD的含量和纯度如表1所示。Treatment object: Bangtai Bioengineering (Shenzhen) Co., Ltd. prepared four batches of crude product solution obtained by NAD using biological enzyme catalysis method (with NMN and ATP as substrates and catalysis with nicotinamide single nucleotide adenosyltransferase). The NAD content and purity in the four batches of crude NAD solution are shown in Table 1.
对上述四批NAD粗产物溶液的纯化过程如下:The purification process of the above four batches of crude NAD solution is as follows:
1.         用盐酸分别将上述四批NAD粗产物溶液的pH值调节至3.0~5.0,然后用0.1~0.5μm孔径的中空纤维膜进行微滤。1. The pH of the four batches of the crude NAD solution was adjusted to 3.0-5.0 with hydrochloric acid, and then microfiltration was performed with a hollow fiber membrane having a pore size of 0.1-0.5 μm.
2.         将微滤后的溶液用截留分子量为200~400道尔顿的纳滤膜进行纳滤浓缩,浓缩至溶液中NAD的浓度为100~300mmol/L。2. The solution after microfiltration was concentrated by nanofiltration with a nanofiltration membrane having a molecular weight cutoff of 200 to 400 Daltons, and concentrated to a concentration of NAD in the solution of 100 to 300 mmol / L.
3.         用氢氧化钠将步骤2浓缩后的溶液的pH值调节至6.0~8.0,调pH的过程中会产生大量的沉淀,主要为高价阳离子沉淀,再次用0.1~0.5μm孔径的中空纤维膜进行微滤,去除沉淀。3. Use sodium hydroxide to adjust the pH value of the solution concentrated in step 2 to 6.0 to 8.0. During the pH adjustment process, a large amount of precipitation will occur, mainly high-valent cation precipitation, and the hollow fiber membrane with a pore size of 0.1 to 0.5 μm is used for micro-adjustment. Filter to remove the precipitate.
4.         将步骤3微滤后的微滤液转移至结晶釜中,开启搅拌装置,将结晶釜的夹套温度设置为35℃,加入乙醇至溶液中乙醇的终浓度为20~40%体积分数,搅拌至溶液澄清。4. Transfer the microfiltration solution from step 3 to the crystallization kettle, turn on the stirring device, set the jacket temperature of the crystallization kettle to 35 ° C, add ethanol to the final ethanol concentration in the solution to 20-40% by volume, and stir until The solution was clear.
5.         将结晶釜的夹套温度设置为6℃,当溶液温度降至6℃后,每隔3h取样检测溶液中NAD的纯度,在线监控溶液中的pH值,并随时用氢氧化钠将溶液的pH值保持在6.0~8.0;待溶液中NAD的纯度大于80%时,将溶液排出,用500目滤布过滤,收集滤液,并用高效液相色谱法检测所得滤液中NAD的纯度,即得上述四批NAD粗产物溶液经一次结晶后的纯度,结果如表2所示。5. Set the jacket temperature of the crystallization kettle to 6 ° C. After the solution temperature drops to 6 ° C, take a sample every 3h to check the purity of the NAD in the solution, monitor the pH value of the solution online, and use sodium hydroxide to adjust the pH of the solution at any time. When the purity of the NAD in the solution is greater than 80%, the solution is discharged, filtered through a 500 mesh filter cloth, the filtrate is collected, and the purity of the NAD in the obtained filtrate is measured by high-performance liquid chromatography to obtain the above four The purity of the batch NAD crude product solution after one time crystallization is shown in Table 2.
6.         将步骤5过滤后的滤液转移至结晶釜中,将结晶釜的夹套温度设置为30℃,待溶液温度大于25℃时,用盐酸将溶液的pH值调节至1.5~3.0之间,并搅拌至澄清。6. Transfer the filtrate filtered in step 5 to the crystallization kettle, set the jacket temperature of the crystallization kettle to 30 ° C, and when the solution temperature is greater than 25 ° C, adjust the pH of the solution to between 1.5 and 3.0 with hydrochloric acid, and stir To clarify.
7.         待溶液澄清后,加入占溶液中NAD质量的0.5%~1.5%的量的NAD晶种,并设置结晶釜的夹套温度为12℃,待溶液温度达到12℃后,每隔3h取样检测NAD的结晶率,当结晶率达到40%时,再向溶液中加入乙醇至溶液中乙醇的终浓度为10~30%体积分数,并用盐酸将溶液的pH值调节至1.5~3.0之间,混合均匀。7. After the solution is clarified, add NAD seeds in an amount of 0.5% to 1.5% of the NAD mass in the solution, and set the jacket temperature of the crystallization kettle to 12 ° C. After the solution temperature reaches 12 ° C, take samples every 3h to detect NAD When the crystallization rate reaches 40%, add ethanol to the solution until the final concentration of ethanol in the solution is 10-30% by volume, and adjust the pH of the solution to between 1.5 and 3.0 with hydrochloric acid and mix well. .
8.         将结晶釜的夹套温度设置为3℃,待溶液到达3℃后,每隔4h取样检测溶液中NAD的转化率,在线监控溶液中的pH值,并随时用盐酸将溶液的pH值保持在1.5~3.0;待溶液中NAD的转化率达到90%以上时,将溶液排出,并进行过滤,然后用10~15℃的体积分数为30%的乙醇水溶液将滤饼洗涤3次,滤饼经真空干燥后即得高纯度NAD产品。8. Set the jacket temperature of the crystallization kettle to 3 ° C. After the solution reaches 3 ° C, take a sample every 4h to detect the NAD conversion in the solution, monitor the pH value of the solution online, and keep the pH of the solution at any time with hydrochloric acid. 1.5 ~ 3.0; when the conversion rate of NAD in the solution reaches more than 90%, the solution is discharged and filtered, and then the filter cake is washed 3 times with a 30% ethanol solution with a volume fraction of 10-15 ° C. High-purity NAD products are obtained after vacuum drying.
测定上述四批纯化后的NAD产品的重量及纯度,并计算收率,其结果如表3所示。The weight and purity of the four purified NAD products were measured, and the yield was calculated. The results are shown in Table 3.
表1Table 1
批次batch 溶液体积/LSolution volume / L NAD含量/gNAD content / g NAD纯度/%NAD purity /%
11 43304330 3659336593 27.327.3
22 40004000 3977439774 25.525.5
33 38003800 4012740127 29.629.6
44 43004300 4397943979 26.926.9
表2Table 2
批次batch 溶液体积/LSolution volume / L 浓度(mmol/L)Concentration (mmol / L) NAD纯度/%NAD purity /%
11 224224 244244 88.388.3
22 253253 234234 95.195.1
33 216216 279279 93.093.0
44 430430 154154 90.690.6
表3table 3
批次batch 产品重量/gProduct weight / g NAD纯度/%NAD purity /% NAD收率/%NAD yield /%
11 3241032410 99.5499.54 88.688.6
22 3705037050 99.3999.39 93.293.2
33 3612036120 99.5899.58 90.090.0
44 3790037900 99.6299.62 86.286.2
 Zh

Claims (11)

  1. 一种制备高纯度NAD的方法,其特征在于,所述方法包括如下步骤:A method for preparing high-purity NAD, characterized in that the method includes the following steps:
    1)将NAD的粗品溶液的pH值调节至6.0~8.0,然后除去不溶物;1) The pH value of the crude NAD solution is adjusted to 6.0 to 8.0, and then the insoluble matter is removed;
    2)升温至35±1℃,并加入乙醇至溶液中乙醇的终浓度为20%~40%体积分数,搅拌至澄清;2) The temperature is raised to 35 ± 1 ° C, and ethanol is added until the final concentration of ethanol in the solution is 20% to 40% by volume, and stirred until clear;
    3)降温至6±0.5℃,保持pH值为6.0~8.0进行结晶,待晶体析出后进行过滤,收集滤液;3) Reduce the temperature to 6 ± 0.5 ° C, maintain the pH value of 6.0-8.0 for crystallization, filter after the crystals precipitate, and collect the filtrate;
    4)将步骤3)的滤液升温至25~30℃,然后调节pH值至1.5~3.0,搅拌至澄清;4) The filtrate of step 3) is heated to 25-30 ° C, and then the pH is adjusted to 1.5-3.0, and stirred until clear;
    5)加入NAD晶种,然后降温至12±0.5℃,保持pH值为1.5~3.0,待溶液中NAD的结晶率达到40%以上时,再加入乙醇至溶液中乙醇的终浓度为10%~30%体积分数,混合均匀;5) Add NAD seed, then cool down to 12 ± 0.5 ℃, keep the pH value 1.5 ~ 3.0, when the crystallization rate of NAD in the solution reaches more than 40%, add ethanol to the final concentration of ethanol in the solution is 10% ~ 30% volume fraction, mix well;
    6)降温至3±0.5℃,保持pH值为1.5~3.0,待溶液中NAD的结晶率在90%以上时,过滤,收集滤饼,经干燥后即得高纯度NAD产品。6) The temperature is reduced to 3 ± 0.5 ° C, the pH value is maintained at 1.5-3.0, and when the crystallization rate of NAD in the solution is above 90%, it is filtered and the filter cake is collected.
  2. 根据权利要求1所述的制备高纯度NAD的方法,其特征在于:所述NAD的粗品溶液的浓度为100~300mmol/L。The method for preparing high-purity NAD according to claim 1, wherein the concentration of the crude NAD solution is 100-300 mmol / L.
  3. 根据权利要求1所述的制备高纯度NAD的方法,其特征在于:所述步骤1)中,采用微滤方式除去不溶物。The method for preparing high-purity NAD according to claim 1, wherein in step 1), insoluble matter is removed by a microfiltration method.
  4. 根据权利要求1所述的制备高纯度NAD的方法,其特征在于:所述步骤3)中,待晶体析出至溶液中NAD的纯度在80%以上时进行过滤。The method for preparing high-purity NAD according to claim 1, characterized in that in the step 3), filtering is performed when the crystals are precipitated into the solution and the purity of NAD is above 80%.
  5. 根据权利要求1所述的制备高纯度NAD的方法,其特征在于:所述步骤5)中,所述NAD晶种的加入量为所述步骤3)的滤液中含有的NAD质量的0.5%~1.5%。The method for preparing high-purity NAD according to claim 1, wherein in the step 5), the amount of the NAD seed added is 0.5% to the mass of the NAD contained in the filtrate of the step 3). 1.5%.
  6. 根据权利要求1所述的制备高纯度NAD的方法,其特征在于:在对步骤6)的滤饼进行干燥之前,先用10~15℃的体积分数为30%±2%的乙醇水溶液对滤饼进行洗涤。The method for preparing high-purity NAD according to claim 1, characterized in that: before drying the filter cake in step 6), the filter is filtered with an aqueous solution of ethanol having a volume fraction of 30% ± 2% at 10 to 15 ° C. The cake was washed.
  7. 根据权利要求1至6任一项所述的制备高纯度NAD的方法,其特征在于:所述NAD的粗品溶液为生物催化法制备NAD得到的粗产物溶液。The method for preparing high-purity NAD according to any one of claims 1 to 6, wherein the crude solution of NAD is a crude product solution obtained by preparing NAD by a biocatalytic method.
  8. 根据权利要求7所述的制备高纯度NAD的方法,其特征在于, 所述方法还包括:在所述步骤1)之前,将所述粗产物溶液进行浓缩处理。The method for preparing a high-purity NAD according to claim 7, further comprising: before the step 1), concentrating the crude product solution.
  9. 根据权利要求7所述的制备高纯度NAD的方法,其特征在于:所述浓缩处理为用截留分子量为200~400道尔顿的纳滤膜进行纳滤浓缩。The method for preparing high-purity NAD according to claim 7, wherein the concentration treatment is nanofiltration concentration using a nanofiltration membrane having a molecular weight cutoff of 200 to 400 Daltons.
  10. 根据权利要求7所述的制备高纯度NAD的方法,其特征在于, 所述方法还包括:在进行浓缩处理之前,将所述粗产物溶液的pH值调节至3.0~5.0,然后进行微滤处理,收集微滤液。The method for preparing high-purity NAD according to claim 7, further comprising: before performing the concentration treatment, adjusting the pH value of the crude product solution to 3.0 to 5.0, and then performing microfiltration treatment Collect the micro filtrate.
  11. 根据权利要求3或10所述的制备高纯度NAD的方法,其特征在于:所述微滤过程中使用的微滤膜为0.1~0.5μm孔径的中空纤维膜。The method for preparing a high-purity NAD according to claim 3 or 10, wherein the microfiltration membrane used in the microfiltration process is a hollow fiber membrane with a pore size of 0.1-0.5 μm.
PCT/CN2018/106903 2018-09-21 2018-09-21 Method for preparing high-purity nad WO2020056713A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/CN2018/106903 WO2020056713A1 (en) 2018-09-21 2018-09-21 Method for preparing high-purity nad
CN201880037981.3A CN111065644B (en) 2018-09-21 2018-09-21 Method for preparing high-purity NAD

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/106903 WO2020056713A1 (en) 2018-09-21 2018-09-21 Method for preparing high-purity nad

Publications (1)

Publication Number Publication Date
WO2020056713A1 true WO2020056713A1 (en) 2020-03-26

Family

ID=69888204

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/106903 WO2020056713A1 (en) 2018-09-21 2018-09-21 Method for preparing high-purity nad

Country Status (2)

Country Link
CN (1) CN111065644B (en)
WO (1) WO2020056713A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113121629A (en) * 2021-03-25 2021-07-16 沁浩膜技术(厦门)有限公司 Method for extracting nicotinamide mononucleotide from fermentation liquor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103027947A (en) * 2011-09-30 2013-04-10 北京因科瑞斯医药科技有限公司 Extraction, separation and purification method for nux vomica total alkali
CN104876994A (en) * 2015-05-19 2015-09-02 邦泰生物工程(深圳)有限公司 Method for purifying oxidized beta-nicotinamide adenine dinucleotide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105131065B (en) * 2015-07-16 2017-02-15 合肥平光制药有限公司 Preparation method of oxidizing-type coenzyme I
CN105481923B (en) * 2015-12-30 2018-07-31 平光制药股份有限公司 A kind of preparation method of nicotinamide adenine dinucleotide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103027947A (en) * 2011-09-30 2013-04-10 北京因科瑞斯医药科技有限公司 Extraction, separation and purification method for nux vomica total alkali
CN104876994A (en) * 2015-05-19 2015-09-02 邦泰生物工程(深圳)有限公司 Method for purifying oxidized beta-nicotinamide adenine dinucleotide

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113121629A (en) * 2021-03-25 2021-07-16 沁浩膜技术(厦门)有限公司 Method for extracting nicotinamide mononucleotide from fermentation liquor
CN113121629B (en) * 2021-03-25 2023-07-21 沁浩膜技术(厦门)有限公司 Method for extracting nicotinamide mononucleotide from fermentation liquor

Also Published As

Publication number Publication date
CN111065644A (en) 2020-04-24
CN111065644B (en) 2022-07-05

Similar Documents

Publication Publication Date Title
CN107058416B (en) Fermentation process for refining glutamic acid
CN102976923B (en) New process for extracting lactic acid from lactic acid fermentation liquid
CN108285912B (en) Method for preparing and extracting pharmaceutical grade valine by fermentation
CN108017535B (en) Method for extracting long-chain dicarboxylic acid from fermentation liquor
CN102363594B (en) Method for separating and purifying succinic acid from fermentation broth
US10765967B2 (en) Process for purifying NADPH
CN106188167A (en) A kind of separation and Extraction N acetyl group D glucosamine and method of D glucosamine from D-glucosamine fermentation liquid
CN110272461B (en) Method for purifying beta-thymidine from fermentation liquor
CN111039808A (en) Method for extracting tyrosine from fermentation liquor
CN107383135B (en) Method for separating and purifying beta-thymidine from fermentation liquor
KR100828706B1 (en) A method for purifying 5'-Inosinic acid fermentation broth via crystallization process
CN113004347B (en) Method for separating and purifying 2' -fucosyllactose
CN111065644B (en) Method for preparing high-purity NAD
CN110204430B (en) Method for purifying quebrachitol crystal crude product
CN108299220B (en) Method for extracting L-4-hydroxyisoleucine from fermentation catalytic liquid
CN113121629B (en) Method for extracting nicotinamide mononucleotide from fermentation liquor
CN115772549A (en) Preparation method for extracting nicotinamide containing trace nicotinic acid from fermentation liquor
CN101492366B (en) Method for extracting allomaleic acid from fermentation liquor
CN110372606B (en) Method for separating and purifying cytosine from microbial fermentation liquor
CN108315375B (en) Production method of oxidized nicotinamide adenine dinucleotide phosphate
CN108034773B (en) Method for producing crystal sugar by utilizing simulated moving bed continuous ion exchange
CN108220351B (en) Method for preparing L-arginine-alpha-ketoglutaric acid by biological enzyme method
CN116496222B (en) Method for separating and purifying tetrahydropyrimidine from fermentation liquor
CN117050021B (en) Method for separating and extracting tetrahydropyrimidine from fermentation liquor
WO2020056714A1 (en) Method for preparing high-purity riboflavin sodium phosphate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18933979

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18933979

Country of ref document: EP

Kind code of ref document: A1